Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02529618 · ClinicalTrials.gov registry record

Field Implementation of iDETECT

A clinical trial, sponsored by Emory University.

Completed
Registry status
124
Enrollment target

NCT02529618: Completed study, sponsored by Emory University.

NCT02529618 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 124 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02529618 has completed, sponsored by Emory University.

COMPLETED
Registry status
124 participants
Enrollment target

Study Summary

The purpose of this study is to assess a new screening tool for sideline evaluation of concussion injuries in athletes. iDETECT is a new technology that combines several elements of recommended concussion screening tools into a single, portable device.

Primary Outcome

The area under the receiver operator characteristic (ROC) curve (the concordance index) for total score of NP will be computed and compared with the trainer's determination of clinical concussion to find out if iDETECT is as accurate in diagnosing concussion.

Interventions

  • DEVICE integrated Display Enhanced Testing for Cognitive Impairment and mild traumatic brain injury (iDETECT)
  • DEVICE Riddell High Impact Technology (HIT) System
  • DEVICE i1 Biometrics Vector Mouth Guard

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2015-08
Est. Completion 2016-02
Emory University

1,208 total trials

What the finished NCT02529618 record still lists

NCT02529618 is an observational study that tracks outcomes without assigning an intervention. The registered 124 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 3 interventions - of which integrated Display Enhanced Testing for Cognitive Impairment and mild traumatic brain injury (iDETECT) is the first listed.

NCT02529618 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02529618 about?

NCT02529618 is a clinical study titled "Field Implementation of iDETECT". The purpose of this study is to assess a new screening tool for sideline evaluation of concussion injuries in athletes. iDETECT is a new technology that combines several elements of recommended concussion screening tools into a single, portable device.

What is the current status of trial NCT02529618?

This trial is currently completed. The enrollment target is 124 participants. The study started on 2015-08. Estimated completion is 2016-02.

What interventions are being tested in trial NCT02529618?

The interventions under investigation include: integrated Display Enhanced Testing for Cognitive Impairment and mild traumatic brain injury (iDETECT) (DEVICE), Riddell High Impact Technology (HIT) System (DEVICE), i1 Biometrics Vector Mouth Guard (DEVICE).

Who is sponsoring clinical trial NCT02529618?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523014 · 124 participants · Phase 2

    Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

  • NCT02670707 · 124 participants · Phase 3

    Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)

  • NCT02830724 · 124 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers

  • NCT04748809 · 124 participants · NA

    Effect of Anti-inflammatory Diet in Rheumatoid Arthritis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02529618, the US trial registry maintained by the National Library of Medicine. NCT02529618 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.